These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Long term clinical follow-up of atypical ductal hyperplasia and lobular carcinoma in situ in breast core needle biopsies. Renshaw AA, Gould EW. Pathology; 2016 Jan; 48(1):25-9. PubMed ID: 27020205 [Abstract] [Full Text] [Related]
7. Atypical lobular hyperplasia or lobular carcinoma in situ at core-needle breast biopsy. Berg WA, Mrose HE, Ioffe OB. Radiology; 2001 Feb; 218(2):503-9. PubMed ID: 11161169 [Abstract] [Full Text] [Related]
9. Uncommon high-risk lesions of the breast diagnosed at stereotactic core-needle biopsy: clinical importance. Philpotts LE, Shaheen NA, Jain KS, Carter D, Lee CH. Radiology; 2000 Sep; 216(3):831-7. PubMed ID: 10966718 [Abstract] [Full Text] [Related]
10. Classic lobular carcinoma in situ and atypical lobular hyperplasia at percutaneous breast core biopsy: outcomes of prospective excision. Murray MP, Luedtke C, Liberman L, Nehhozina T, Akram M, Brogi E. Cancer; 2013 Mar 01; 119(5):1073-9. PubMed ID: 23132235 [Abstract] [Full Text] [Related]
12. Excisional biopsy should be performed if lobular carcinoma in situ is seen on needle core biopsy. Shin SJ, Rosen PP. Arch Pathol Lab Med; 2002 Jun 01; 126(6):697-701. PubMed ID: 12033958 [Abstract] [Full Text] [Related]
18. The significance of lobular carcinoma in situ and atypical lobular hyperplasia of the breast. Lewis JL, Lee DY, Tartter PI. Ann Surg Oncol; 2012 Dec 01; 19(13):4124-8. PubMed ID: 22847126 [Abstract] [Full Text] [Related]